Role of dipeptidyl peptidase-4 as a potentiator of activin/nodal signaling pathway
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
DPP4 (dipeptidyl peptidase-4), a highly conserved transmembrane glycoprotein with an exo-peptidase activity, has been shown to contribute to glucose metabolism, immune regulation, signal transduction, and cell differentiation. Here, we show that DPP4 is involved in control of activin/nodal signaling in Xenopus early development. In support of this, gain of function of DPP4 augmented Smad2 phosphorylation as well as expression of target genes induced by activin or nodal signal. In addition, Dpp4 and Xnr1 showed synergistic effect on induction of ectopic dorsal body axis, when co-injected at suboptimal doses in early embryos. Conversely, saxagliptin, a DPP4 inhibitor repressed activin induction of Smad2 phosphorylation. Notably, overexpression of Dpp4 disrupted specification of dorsal body axis of embryo, leading to malformed phenotypes such as spina bifida and a shortened and dorsally bent axis. Together, these results suggest that DPP4 functions as a potentiator of activin/nodal signaling pathway.
Abstract
DPP4 (dipeptidyl peptidase-4), a highly conserved transmembrane glycoprotein with an exo-peptidase activity, has been shown to contribute to glucose metabolism, immune regulation, signal transduction, and cell differentiation. Here, we show that DPP4 is involved in control of activin/nodal signaling in Xenopus early development. In support of this, gain of function of DPP4 augmented Smad2 phosphorylation as well as expression of target genes induced by activin or nodal signal. In addition, Dpp4 and Xnr1 showed synergistic effect on induction of ectopic dorsal body axis, when co-injected at suboptimal doses in early embryos. Conversely, saxagliptin, a DPP4 inhibitor repressed activin induction of Smad2 phosphorylation. Notably, overexpression of Dpp4 disrupted specification of dorsal body axis of embryo, leading to malformed phenotypes such as spina bifida and a shortened and dorsally bent axis. Together, these results suggest that DPP4 functions as a potentiator of activin/nodal signaling pathway.
참고문헌 (28)
- Massague J, "TGFbeta in Cancer", Cell, 134, pp.215~230 (2008)
- Massague J, "TGFbeta signalling in context", Nat Rev Mol Cell Biol, 13, pp.616~630 (2012)
- Wakefield LM, "Beyond TGFbeta: roles of other TGFbeta superfamily members in cancer", Nat Rev Cancer, 13, pp.328~341 (2013)
- Dale L, "BMP signalling in early Xenopus development", Bioessays, 21, pp.751~760 (1999)
- Shen MM, "Nodal signaling: developmental roles and regulation", Development, 134, pp.1023~1034 (2007)
- Whitman M, "Nodal signaling in early vertebrate embryos: themes and variations", Dev Cell, 1, pp.605~617 (2001)
- Derynck R, "Smad-dependent and Smad-independent pathways in TGF-beta family signalling", Nature, 425, pp.577~584 (2003)
- Pro B, "CD26", dipeptidyl peptidase IV and its role in cancer, 2004, pp.19, 1345~1351
- Glorie L, "Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors", Bone, 92, pp.37~49 (2016)
- Lambeir AM, "Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV", Crit Rev Clin Lab Sci, 40, pp.209~294 (2003)
- Lone AM, "Peptidomics of the prolyl peptidases", AAPS J, 12, pp.483~491 (2010)
- Chen X, "Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8", Adv Exp Med Biol, 575, pp.27~32 (2006)
- Marguet D, "Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26", Proc Natl Acad Sci U S A, 97, pp.6874~6879 (2000)
- Masur K, "DPPIV inhibitors extend GLP-2mediated tumour promoting effects on intestinal cancer cells", Regul Pept, 137, pp.147~155 (2006)
- Wesley UV, "Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway", Cancer Res, 65, pp.1325~1334 (2005)
- Niederlander C, "Arkadia enhances nodal-related signalling to induce mesendoderm", Nature, 410, pp.830~834 (2001)
- Shi S, "Linagliptin but not Sitagliptin inhibited transforming growth factor-beta2-induced endothelial DPP-4 activity and the endothelialmesenchymal transition", Biochem Biophys Res Commun, 471, pp.184~190 (2016)
- Agius E, "Endodermal Nodal-related signals and mesoderm induction in Xenopus", Development, 127, pp.1173~1183 (2000)
- Branford WW, "Lefty-dependent inhibition of Nodal-and Wnt-responsive organizer gene expression is essential for normal gastrulation", Curr Biol, 12, pp.2136~2141 (2002)
- Houston DW, "Maternal Xenopus Zic2negatively regulates Nodal-related gene expression during anteroposterior patterning", Development, 132, pp.4845~4855 (2005)
- Osada SI, "Xenopus nodal-related signaling is essential for mesendodermal patterning during early embryogenesis", Development, 126, pp.3229~3240 (1999)
- Yun CH, "Negative regulation of Activin", Nodal signaling by SRF during Xenopus gastrulation, 2007, pp.134, 769~777
- Golightly LK, "Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors", Clin Pharmacokinet, 51, pp.501~514 (2012)
- Nieuwkoop PD, "Normal table of Xenopus laevis (Daudin) :a systematical and chronological survey of the development from the fertilized egg till the end of metamorphosis" (1994), Garland Pub
- Maeno M, "A truncated bone morphogenetic protein 4receptor alters the fate of ventral mesoderm to dorsal", Proc Natl Acad Sci U S A, 91, pp.10260~10264 (1994)
- Wilson PA, "Mesodermal patterning by an inducer gradient depends on secondary cell-cell communication", Curr Biol, 4, pp.676~686 (1994)
- Harland RM, "In situ hybridization: an improved whole-mount method for Xenopus embryos", Methods Cell Biol, 36, pp.685~695 (1991)
- Cho KW, "Molecular nature of Spemann's organizer: the role of the Xenopus homeobox gene goosecoid", Cell, 67, pp.1111~1120 (1991)